NECTIN4 and neoplasm: We showed that NECTIN4-CAR T cells exhibit high specificity and potency across a range of UC models, including EV resistant cells, and that NECTIN4-CAR T antitumor activity can be enhanced by short-term priming of tumor cells with TZDs such as rosiglitazone.